In a filing, Elevance Health Inc revealed its CAO & Controller Penczek Ronald W unloaded Company’s shares for reported $0.18 million on Mar 10 ’25. In the deal valued at $415.13 per share,443 shares were sold. As a result of this transaction, Penczek Ronald W now holds 1,847 shares worth roughly $0.8 million.
Then, Penczek Ronald W bought 443 shares, generating $183,904 in total proceeds.
Before that, Kendrick Charles Morgan JR sold 3,504 shares. Elevance Health Inc shares valued at $1,388,635 were divested by the EVP & President, Commercial at a price of $396.30 per share. As a result of the transaction, Kendrick Charles Morgan JR now holds 10,116 shares, worth roughly $4.36 million.
Argus upgraded its Elevance Health Inc [ELV] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Stephens’s analysts, who decreased its forecast for the stock in late January from “an Overweight” to “an Equal-weight”. Argus also remained covering ELV and has decreased its forecast on October 18, 2024 with a “Hold” recommendation from previously “Buy” rating. BofA Securities revised its rating on July 18, 2024. It rated ELV as “a Neutral” which previously was an “a Buy”.
Price Performance Review of ELV
On Monday, Elevance Health Inc [NYSE:ELV] saw its stock jump 2.29% to $430.59. Over the last five days, the stock has gained 5.14%. Elevance Health Inc shares have risen nearly 16.72% since the year began. Nevertheless, the stocks have fallen -15.49% over the past one year. While a 52-week high of $567.26 was reached on 03/17/25, a 52-week low of $362.21 was recorded on 01/02/25. SMA at 50 days reached $395.55, while 200 days put it at $462.51.
Levels Of Support And Resistance For ELV Stock
The 24-hour chart illustrates a support level at 423.88, which if violated will result in even more drops to 417.18. On the upside, there is a resistance level at 434.63. A further resistance level may holdings at 438.68. The Relative Strength Index (RSI) on the 14-day chart is 67.61, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 16.52, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 2.93%. Stochastics %K at 86.88% indicates the stock is a selling.
How much short interest is there in Elevance Health Inc?
A steep rise in short interest was recorded in Elevance Health Inc stocks on 2025-02-28, dropping by -0.33 million shares to a total of 2.48 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 2.81 million shares. There was a decline of -13.47%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 24, 2024 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating along with a $643 price target.
